Characterization of high affinity neurotensin receptor NTR1 in HL-60 cells and its down regulation during granulocytic differentiation

British Journal of Pharmacology

Volumn 126, Issue 4, 1999, Pages 1050-1056

  Choi, Se Young ^a,b   Chae, Hee Don ^a   Park, Tae Ju ^a   Ha, Hyunjung ^a   Kim, Kyong Tai ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Chungbuk National University   (South Korea)

Author keywords

Cytosolic Ca2+; Differentiation; Human hemopoietic cells; Neurotensin; Phospholipase C

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; CALCIUM ION; DIMETHYL SULFOXIDE; INOSITOL 1,4,5 TRISPHOSPHATE; LEVOCABASTINE; MESSENGER RNA; NEUROMEDIN N; NEUROTENSIN; NEUROTENSIN RECEPTOR; NEUROTENSIN[8-13]; XENOPSIN;

ARTICLE; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONCENTRATION RESPONSE; CONTROLLED STUDY; GRANULOCYTE; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032911441     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702378     Document Type: Article

References (40)

1. AMAR, S., MAZELLA, J., CHECLER, F., KITABGI, P. & VINCENT. J.P. (1985). Regulation of cyclic GMP levels by neurotensin in neuroblastoma clone N1E115. Biochem. Biophys. Res. Commun., 129, 117-125.
2. BACHELARD, H., GARDINER, S.M., KEMP, P.A. & BENNETT, T. (1992). Mechanisms contributing to the regional haemodynamic effects of neurotensin in conscious, unrestrained Long Evans rats. Br. J. Pharmacol., 105, 191-201.
3. BOZOU, J.C., AMAR, S., VINCENT, J.P. & KITABGI, P. (1986). Neurotensin-mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells: involvement of the inhibitory GTPbinding component of adenylate cyclase. Afol. Pharmacol., 29, 489-496.
4. BOZOU, J.C., ROCHET, N., MAGNALDO, I., VINCENT, J.P. & KITABGI, P. (1989). Neurotensin stimulates inositol trisphosphate-mediated calcium mobilization but not protein kinase C activation in HT29 cells. Biochem. J., 264, 871-878.
5. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
6. BUHNER, S. & EHRLEIN, H.J. (1989). Effects of neurotensin on motor patterns of canine duodenum and proximal jejunum. Can. J. Physiol. Pharmacol., 67, 1534-1539.
7. CHABRY, J., CHECLER, F., VINCENT, J.P. & MAZELLA, J. (1990). Colocalization of neurotensin receptors and of the neurotensin-degrading enzyme endopeptidase 24-16 in primary cultures of neurons. J. Neurosci., 10, 3916-3921.
8. CHALON, P., VITA, N., KAGHAD, M., GUILLEMOT, M., BONNIN, J., DELPECH, B., LE FUR, G., FERRARA, P. & CAPUT, D. (1996). Molecular cloning of a levocabastine-sensitive neurotensin binding site. FEBS Lett., 386, 91 -94.
9. CHOI, S.Y. & KIM, K.T. (1997). Extracellular ATP-mediated increase of cytosolic cAMP in HL-60 cells. Biochem. Pharmacol., 53,429-432.
10. CHOMCZYNSKI, P. & SACCHI, N. (1987). Single-step method of RNA isolation by acidic guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem., 162, 156-159.
11. COLLINS, S.J., RUSCETTI, F.W., GALLAGHER, R.E. & GALLO, R.C. (1978). Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sei. U.S.A., 75, 2458-2462.
12. COOK, N., DEXTER, T.M., LORD, B.I., CRAGOE, JR E.J. & WHETTON, A.D. (1989). Identification of a common signal associated with cellular proliferation stimulated by four haemopoietic growth factors in a highly enriched population of granulocyte/macrophage colony-forming cells. EMBO J., 8, 2967-2974.
13. DE LEAN, A., MUNSON, P.J. & RODBARD, D. (1978). Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J.Physiol.,235,E91-E102.
14. GILBERT, J.A. & RICHELSON, E. (1984). Neurotensin stimulates formation of cyclic GMP in murine neuroblastoma clone N1E115. Eur. J. Pharmacol., 99, 245-246.
15. GOEDERT, M., PINNOCK, R.D., DOWNES, C.P., MANTYH, P.W. & EMSON, P.C. (1984). Neurotensin stimulates inositol phospholipases hydrolysis in rat brain slices. Brain Res., 323, 193-197.
16. GOLDMAN, R. & BAR-SHAVIT, Z. (1983). On the mechanism of the augmentation of the phagocytic capability of phagocytic cells by Tuftsin, substance P, neurotensin, and kentsin and the interrelationship between their receptors. Ann. N.Y. Acad. Sei., 419, 143-155.
17. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
18. GULLY, D., CANTON, M., BOIGEGRAIN, R., JEANJEAN, F., MOLIMARD, J.C., PONCELET, M., GUEUDET, C, HEAULME, M., LEYRIS, R., BROUARD, A., PELAPRAT, D., LABBE-JULLIE, C., MAZELLA, J., SOUBRIE, P., MAFFRAND, J.P., ROSTENE, W., KITABGI, P. & LE FUR, G. (1993). Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc. Natl. Acad. Sei. U.S.A., 90, 65-69.
19. HERMANS, E., MALOTEAUX, J.M. & OCTAVE, J.N. (1992). Phospholipase C activation by neurotensin and neuromedin N in Chinese hamster ovary cells expressing the rat neurotensin receptor. Mol. Brain Res., 15, 332-338.
20. KITABGI, P., CHECLER, F., MAZELLA, J. & VINCENT, J.P. (1985). Pharmacology and biochemistry of neurotensin receptors. Rev. Clin. Basic Pharmacol., 5, 397-486.
21. KLINKER, J.F., WENZEL-SEIFERT, K. & SEIFERT, R. (1996). G-protein-coupled receptors in HL-60 human leukemia cells. Gen. Pharmacol., 27, 33-54.
22. LAZARUS, L.H., PERRIN, M.H., BROWN, M.R. & RIVIER, J.E. (1977). Mast cell binding of neurotensin. J. Biol. Chem., 252,7180-7183.
23. 2+ entry. J. Biol. Chem., 272, 21831 -21838.
24. MAZELLA, J., BOTTO, J.M., GUILLEMARE, E., COPPOLA, T., SARRET, P. & VINCENT, J.P. (1996). Structure, functional expression, and cerebral localization of the levocabastinesensitive neurotensin/neuromedin N receptor from mouse brain. J. Neurosci., 16, 5613-5620.
25. MAZELLA, J., CHABRY, J., KITABGI, P. & VINCENT, J.P. (1988). Solubilization and characterization of active neurotensin receptors from mouse brain. J. Biol. Client., 263, 144-149.
26. MAZELLA, J., KITABGI, P. & VINCENT, J.P. (1985). Molecular properties of neurotensin receptors in rat brain. Identification of subunits by covalent labeling. J. Biol. Client., 260, 508-514.
27. MOORE, R.N., OSMAND, A.P., DUNN, J.A., HOSHI, J.G., KOONTZ, J.W. & ROUSE, B.T. (1989). Neurotensin regulation of macrophage colony-stimulating factor-stimulated in vitro myelopoesis. J. ImnnmoL, 142, 2689-2694.
28. NEMEROFF, C.B., LEVANT, B., MYERS, B. & BISSETTE, G. (1992). Neurotensin, antipsychotic drugs, and schizophrenia: basic and clinical studies. Ann. N.Y. Acad. Sei.. 668, 146-156.
29. PEMBER, S.O., SHAPIRA, R. & KINKADE, J.M. (1983). Multiple forms of myeloperoxidase from human neutrophilic granulocytes: evidence for differences in compartmentalization, enzymatic activity, and subunit structure. Arch. Biochem. Biophys., 221, 391-403.
30. SCHAEFFER, P., LAPLACE, M.C., PRABONNAUD, V., BERNAT, A., GULLY, D., LESPY, L. & HERBERT, J.M. (1997). Neurotensin induces the release of prostacyclin from human umbilical vein endothelial cells in vitro and increases plasma prostacyclin levels in the rat. EUT. J. Pharmacol., 323, 215-221.
31. SCHAEFFER, P., LAPLACE, M.C., SAVI, P., PFLIEGER, A.M., GULLY, D. & HERBERT, J.M. (1995). Human umbilical vein endothelial cells express high affinity neurotensin receptors coupled to intracellular calcium release. J. Biol. Chem., 270, 3409-3413.
32. SCHIMPFF, R.M., GOURMELEN, M., SCARCERIAUX, V., LHIAUBET, A.M. & ROSTENE, W. (1995). Plasma neurotensin levels in humans: relation to hormone levels in diseases involving the hypothalamo-pituitary-thyroid axis. Eur. J. Endocrinol., 133, 534-538.
33. 3H]neurotensin binding site in rat brain. Naunyn. Schmiedebergs Arch. Pharmacol.. 333, 400-405.
34. SEO, J.K., CHOI, S.Y., KIM, Y., BAEK, S.U., KIM, K.T., CHAE, C.B., LAMBETH, J.D., SUH, P.C. & RYU, S.U. (1997). A peptide with unique receptor specificity: stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils. J. ImmunoL, 158, 1895-1901.
35. SHI, W.X. & BUNNEY, B.S. (1992a). Actions of neurotensin: a review of the electrophysiological studies. Ann. N.Y. Acad. Sei., 668, 129-145.
36. SHI, W.X. & BUNNEY, B.S. (1992b). Roles of intracellular cAMP and protein kinase A in the actions of dopamine and neurotensin on midbrain dopamine neurons. J. Neurosci., 12, 2433-2438.
37. TANAKA, K., MASU, M. & NAKANISHI, S. (1990). Structure and functional expression of the cloned rat neurotensin receptor. Neuron, 4, 847-854.
38. VINCENT, J.P. (1995). Neurotensin receptors: binding properties, transduction pathways, and structure. Cell. Mol. Neurobiol., 15, 501-512.
39. VITA, N., LAURENT, P., LEFORT, S., CHALON, P., DUMONT, X., KAGHAD, M., GULLY, D., LE FUR, G., FERRARA, P. & CAPUT, D. (1993). Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEES Lett. .317, 139-142.
40. YAMADA, M., YAMADA, M., WATSON, M.A. & RICHELSON, E. (1994). Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells. Mol. Pharmacol., 46, 470-476.